0001209191-21-069422.txt : 20211214
0001209191-21-069422.hdr.sgml : 20211214
20211214162101
ACCESSION NUMBER: 0001209191-21-069422
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211210
FILED AS OF DATE: 20211214
DATE AS OF CHANGE: 20211214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farwell Wildon
CENTRAL INDEX KEY: 0001847941
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39509
FILM NUMBER: 211491216
MAIL ADDRESS:
STREET 1: C/O DYNE THERAPEUTICS, INC.
CITY: 830 WINTER STREET
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dyne Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818794
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364883909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 786-8230
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-10
0
0001818794
Dyne Therapeutics, Inc.
DYN
0001847941
Farwell Wildon
C/O DYNE THERAPEUTICS, INC.
1560 TRAPELO ROAD
WALTHAM
MA
02451
0
1
0
0
Chief Medical Officer
Common Stock
2021-12-10
4
A
0
22307
0.00
A
72307
D
Stock Option (right to buy)
13.12
2021-12-10
4
A
0
67935
0.00
A
2031-12-09
Common Stock
67935
67935
D
Consists of shares of Common Stock issuable under 22,307 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on March 10, 2022.
Includes 72,307 unvested RSUs. Each unvested RSU represents the right to receive one share of Common Stock upon vesting.
This option was granted on December 10, 2021. The shares underlying the option are scheduled to vest over four years in equal monthly installments through December 10, 2025.
/s/ Richard Scalzo, Attorney-in-Fact
2021-12-14